These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2961853)
21. A role for 5HT3 receptors in visual processing in the mammalian retina. Brunken WJ; Jin XT Vis Neurosci; 1993; 10(3):511-22. PubMed ID: 8494802 [TBL] [Abstract][Full Text] [Related]
22. Mechanism and site of action of a dopamine D1 antagonist in the rabbit retina. Jensen RJ Vis Neurosci; 1989 Dec; 3(6):573-85. PubMed ID: 2562113 [TBL] [Abstract][Full Text] [Related]
23. Effects of dopamine and its agonists and antagonists on the receptive field properties of ganglion cells in the rabbit retina. Jensen RJ; Daw NW Neuroscience; 1986 Mar; 17(3):837-55. PubMed ID: 3703255 [TBL] [Abstract][Full Text] [Related]
24. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants. Berendsen HH; Broekkamp CL Psychopharmacology (Berl); 1991; 105(2):219-24. PubMed ID: 1839064 [TBL] [Abstract][Full Text] [Related]
25. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Goodwin GM; Green AR Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582 [TBL] [Abstract][Full Text] [Related]
26. Inhibition by 8-hydroxy-2-(di-n-propylamino) tetralin and SM-3997, a novel anxiolytic drug, of the hippocampal rhythmical slow activity mediated by 5-hydroxytryptamine1A receptors. Hirose A; Tsuji R; Shimizu H; Tatsuno T; Tanaka H; Kumasaka Y; Nakamura M Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):8-13. PubMed ID: 1969119 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. May JA; McLaughlin MA; Sharif NA; Hellberg MR; Dean TR J Pharmacol Exp Ther; 2003 Jul; 306(1):301-9. PubMed ID: 12676887 [TBL] [Abstract][Full Text] [Related]
28. Potential mechanisms involved in the negative coupling between serotonin 5-HT1A receptors and carbachol-stimulated phosphoinositide turnover in the rat hippocampus. Claustre Y; Benavides J; Scatton B J Neurochem; 1991 Apr; 56(4):1276-85. PubMed ID: 1848278 [TBL] [Abstract][Full Text] [Related]
29. The relation of central 5-HT1A and 5-HT2 receptors: low dose agonist-induced selective tolerance in the rat. Pranzatelli MR; Pluchino RS Pharmacol Biochem Behav; 1991 Jun; 39(2):407-13. PubMed ID: 1835098 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats. Arnt J Pharmacol Toxicol; 1989 Feb; 64(2):165-72. PubMed ID: 2526950 [TBL] [Abstract][Full Text] [Related]
31. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471 [TBL] [Abstract][Full Text] [Related]
32. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine. Wieland S; Kreider MS; McGonigle P; Lucki I Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505 [TBL] [Abstract][Full Text] [Related]
33. Effects of dopamine antagonists on receptive fields of brisk cells and directionally selective cells in the rabbit retina. Jensen RJ; Daw NW J Neurosci; 1984 Dec; 4(12):2972-85. PubMed ID: 6502216 [TBL] [Abstract][Full Text] [Related]
34. 5-Hydroxytryptamine responses in neonate rat motoneurones in vitro. Wang MY; Dun NJ J Physiol; 1990 Nov; 430():87-103. PubMed ID: 2150862 [TBL] [Abstract][Full Text] [Related]
35. Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors. Smith BN; Sollars PJ; Dudek FE; Pickard GE J Biol Rhythms; 2001 Feb; 16(1):25-38. PubMed ID: 11220775 [TBL] [Abstract][Full Text] [Related]
36. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin. Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561 [TBL] [Abstract][Full Text] [Related]
37. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors. Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650 [TBL] [Abstract][Full Text] [Related]
38. Benzodiazepine-induced shaking behavior in the rat: structure-activity and relation to serotonin and benzodiazepine receptors. Pranzatelli MR Exp Neurol; 1989 Jun; 104(3):241-50. PubMed ID: 2542077 [TBL] [Abstract][Full Text] [Related]
39. Brainstem 5-hydroxytrytamine1A binding sites are not down-regulated by agonists which induce tolerance in the rat: myoclonus and other serotonergic behaviors. Murthy JN; Pranzatelli MR J Recept Res; 1992; 12(3):287-97. PubMed ID: 1387164 [TBL] [Abstract][Full Text] [Related]
40. Do functional relationships exist between 5-HT1A and 5-HT2 receptors? Darmani NA; Martin BR; Pandey U; Glennon RA Pharmacol Biochem Behav; 1990 Aug; 36(4):901-6. PubMed ID: 2145593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]